An Official Website of the United States Government
Company Information:
Name:
ISOTHERAPEUTICS GROUP, LLC
Address:
1004 S. Velasco
Angleton, TX 77515-5250
Angleton, TX 77515-5250
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
A new radiopharmaceutical for the treatment of metastatic bone cancer
Award Year / Program / Phase:
2010 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Jaime N. Simon
Award Amount:
$143,582.00
Abstract:
DESCRIPTION (provided by applicant): Bone-seeking radiopharmaceuticals are used extensively for bone pain palliation and have shown promise for treating bone metastases. They typically combine a radioactive metal such as samarium-153 with a chelator. The
chelator part of the molecule is taken up… More
High Specific Activity Sm-153 by Post Irradiation Isotope Separation
Award Year / Program / Phase:
2011 / SBIR / Phase I
Agency:
DOE
Principal Investigator:
Jaime Simon, Dr. – 979-848-0800
Award Amount:
$149,476.00
Abstract:
When the stable samarium-152 (Sm-152) isotope is irradiated, radioactive samarium-153 (Sm-153) is produced through a neutron capture reaction in yields of only about 2%, and this radioactive, therapeutic isotope (Sm-153) cannot be separated from the much more abundant (~98%) non-radioactive isotope… More
High Specific Activity Sm-153 by Post Irradiation Isotope Separation
Award Year / Program / Phase:
2012 / SBIR / Phase II
Agency:
DOE
Principal Investigator:
Jaime Simon, Dr. – 979-848-0800
Award Amount:
$989,748.00
Abstract:
Samarium-153 (153Sm) has ideal nuclear properties for a variety of therapeutic applications; however, it is only available in low specific activity (radioactivity/weight) form. While large quantities can be made by the 152Sm(n,)153Sm reaction in a medium flux reactor such as at the University… More